We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
- Authors
Lindholm, Lars H; Ibsen, Hans; Dahlöf, Björn; Devereux, Richard B; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Julius, Stevo; Kjeldsen, Sverre E; Kristiansson, Krister; Lederballe-Pedersen, Ole; Nieminen, Markku S; Omvik, Per; Oparil, Suzanne; Wedel, Hans; Aurup, Peter; Edelman, Jonathan; Snapinn, Steven; LIFE Study Group
- Abstract
The most suitable antihypertensive drug to reduce the risk of cardiovascular disease in patients with hypertension and diabetes is unclear. In prespecified analyses, we compared the effects of losartan and atenolol on cardiovascular morbidity and mortality in diabetic patients.
- Publication
Lancet (London, England), 2002, Vol 359, Issue 9311, p1004
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(02)08090-X